Sunshine Biopharma, Inc.
SBFM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,105 | $6,606 | $9,715 | $7,634 |
| - Cash | $9,687 | $16,292 | $21,826 | $2,045 |
| + Debt | $952 | $658 | $765 | $1,900 |
| Enterprise Value | -$6,629 | -$9,029 | -$11,346 | $7,488 |
| Revenue | $34,874 | $24,093 | $4,346 | $228 |
| % Growth | 44.7% | 454.4% | 1,802.6% | – |
| Gross Profit | $10,670 | $8,339 | $1,697 | $111 |
| % Margin | 30.6% | 34.6% | 39% | 48.4% |
| EBITDA | -$5,154 | -$3,824 | -$26,447 | -$12,095 |
| % Margin | -14.8% | -15.9% | -608.5% | -5,294.9% |
| Net Income | -$5,134 | -$4,506 | -$26,744 | -$12,436 |
| % Margin | -14.7% | -18.7% | -615.4% | -5,444.2% |
| EPS Diluted | -7.32 | -351.36 | -3,523.64 | -9,520 |
| % Growth | 97.9% | 90% | 63% | – |
| Operating Cash Flow | -$12,531 | -$8,775 | -$5,248 | -$1,829 |
| Capital Expenditures | -$2,321 | -$788 | -$305 | $0 |
| Free Cash Flow | -$14,852 | -$9,563 | -$5,553 | -$1,829 |